Gene · 3425
Papers1,870
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,870
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reticulocyte hemoglobin content: a new frontier in iron deficiency diagnostics for major surgical patients. | BMC Anesthesiol | 2025 | 39863874 | PubTator, text mining | PubMed |
| Digital microfluidic platform for dried blood spot newborn screening of lysosomal storage diseases in Campania region (Italy): Findings from the first year pilot project. | Mol Genet Metab | 2025 | 39788860 | PubTator, text mining | PubMed |
| Prenatal diagnosis of mucopolysaccharidosis type I on hepatosplenomegaly and coarse features: a case-report. | BMC Pregnancy Childbirth | 2025 | 39754079 | PubTator, text mining | PubMed |
| Newborn Screening for Hurler Syndrome Facilitates Early Transplant and Good Outcomes. | Pediatr Neurol | 2025 | 39642684 | PubTator, text mining | PubMed |
| Comparing Outcomes Between CPX-351 and Fludarabine-Based Induction in Secondary Acute Myeloid Leukemia in the Real-World Setting: The Prognostic Role of Measurable Residual Disease. | Hematol Oncol | 2025 | 39635952 | PubTator, text mining | PubMed |
| Long-Term Health Outcomes of Individuals With Pseudodeficiency Alleles in IDUA May Inform Newborn Screening Practices for Mucopolysaccharidosis Type I. | Am J Med Genet A | 2025 | 39559959 | PubTator, text mining | PubMed |
Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 Trial. | J Clin Oncol | 2025 | 39556780 | PubTator, text mining | PubMed |
| Improved specificity and efficiency of in vivo adenine base editing therapies with hybrid guide RNAs. | bioRxiv | 2025 | 38712058 | PubTator, text mining | PubMed |
| Cardiovascular Risk Biomarkers in Women with and Without Polycystic Ovary Syndrome. | Biomolecules | 2024 | 39858399 | PubTator, text mining | PubMed |
| Functional assessment of IDUA variants of uncertain significance identified by newborn screening. | NPJ Genom Med | 2024 | 39702574 | PubTator, text mining | PubMed |
| Use It or Lose It: Facilitating the Use of Interactive Data Apps in Psychological Research Data Sharing. | Eur J Psychol | 2024 | 39678926 | PubTator, text mining | PubMed |
| DNAH3 deficiency causes flagellar inner dynein arm loss and male infertility in humans and mice. | Elife | 2024 | 39503742 | PubTator, text mining | PubMed |
| Alterations in Hurler-Scheie Syndrome Revealed by Mass Spectrometry-Based Proteomics and Phosphoproteomics Analysis. | OMICS | 2024 | 39469785 | PubTator, text mining | PubMed |
| Engineering memory T cells as a platform for long-term enzyme replacement therapy in lysosomal storage disorders. | Mol Ther | 2024 | 39367605 | PubTator, text mining | PubMed |
| Circulating ECM proteins decorin and alpha-L-iduronidase differentiate ATTRwt-CM from ATTRwt-negative HFpEF/HFmrEF. | Cardiovasc Res | 2024 | 39288026 | PubTator, text mining | PubMed |
| Challenges in Diagnosing and Managing Hurler Syndrome: A Case Report. | Cureus | 2024 | 39286678 | PubTator, text mining | PubMed |
| Improving protein function prediction by learning and integrating representations of protein sequences and function labels. | Bioinform Adv | 2024 | 39233898 | PubTator, text mining | PubMed |
| Whole paternal uniparental disomy of chromosome 4 with a novel homozygous IDUA splicing variant, c.159-9T>A, in a Chinese patient with mucopolysaccharidosis type I. | Mol Genet Genomic Med | 2024 | 39132856 | PubTator, text mining | PubMed |
| Synergistic effects of resveratrol and enzyme replacement therapy in the Mucopolysaccharidosis type I. | Biochem Pharmacol | 2024 | 39111602 | PubTator, text mining | PubMed |
| Programmable DNA pyrimidine base editing via engineered uracil-DNA glycosylase. | Nat Commun | 2024 | 39080265 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3425/papers?page=5